EUVIMEDEUVIMED entdecken
Crossref

Scenario-based analysis of stage distribution and stage-specific survival among Māori diagnosed with lung cancer in Aotearoa New Zealand

Michael Walsh, Karen Bartholomew, Jason Gurney, Kate Parker, Dale Bramley, Sue Crengle

New Zealand Medical Journal · 20.11.2026 · 139 (1646) · 75-87

DOI: 10.26635/6965.7656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 20.11.2026. Verfasst von Michael Walsh und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

introduction: Lung cancer survival in Aotearoa New Zealand differs between Māori and European populations. This study used scenario-based standardisation to compare survival when Māori estimates were standardised to the European stage distribution, stage-specific survival or both. The scenarios aimed to assess which of these differences was associated with the larger change in estimated survival. methods: National cancer registry data were used to identify all primary lung cancers for Māori and European populations diagnosed between 2015 and 2024, with mortality follow-up to December 2025. Survival was modelled using sex-specific Cox regression, including age at diagnosis and diagnosis year, ethnicity, Surveillance, Epidemiology, and End Results (SEER) summary stage, and an ethnicity-by-stage interaction. Survival probabilities at 1, 3 and 5 years were estimated. Scenarios were constructed for Māori in which stage distribution, stage-specific survival or both were standardised to those of Europeans. results: Five-year survival was lower for Māori than for Europeans among males (11.3%, 95% confidence interval [CI] 9.4–13.7 vs 16.8%, 95% CI 15.2–18.7) and females (17.1%, 95% CI 15.0–19.5 vs 24.2%, 95% CI 22.5–26.2). Standardising stage distribution increased estimated 5-year survival to 13.5% (95% CI 11.4–16.2) for Māori males and 20.2% (95% CI 17.9–22.9) for Māori females. Standardising stage-specific survival produced larger increases, to 17.2% (95% CI 15.4–19.3) and 23.4% (95% CI 21.5–25.6), respectively. Estimates were highest when both were standardised, at 19.5% (95% CI 17.7–21.7) and 26.6% (95% CI 24.7–28.8). conclusions: Differences in both stage distribution and stage-specific survival were associated with lung cancer survival inequities. Standardising stage-specific survival produced a larger change than standardising stage distribution alone.

Zitieren

APA

Walsh, M., Bartholomew, K., Gurney, J., Parker, K., Bramley, D., & Crengle, S. (2026). Scenario-based analysis of stage distribution and stage-specific survival among Māori diagnosed with lung cancer in Aotearoa New Zealand. New Zealand Medical Journal, 139(1646), 75-87. https://doi.org/10.26635/6965.7656

Vancouver

Walsh M, Bartholomew K, Gurney J, Parker K, Bramley D, Crengle S. Scenario-based analysis of stage distribution and stage-specific survival among Māori diagnosed with lung cancer in Aotearoa New Zealand. New Zealand Medical Journal. 2026;139(1646):75-87. doi:10.26635/6965.7656

BibTeX
@article{Walsh2026,
  author = {Walsh, Michael and Bartholomew, Karen and Gurney, Jason and Parker, Kate and Bramley, Dale and Crengle, Sue},
  title = {Scenario-based analysis of stage distribution and stage-specific survival among Māori diagnosed with lung cancer in Aotearoa New Zealand},
  journal = {New Zealand Medical Journal},
  year = {2026},
  volume = {139},
  number = {1646},
  pages = {75--87},
  doi = {10.26635/6965.7656}
}
Kostenlos starten →